- Home
- CPS vs VNDA Comparison
CPS vs VNDA Comparison
Compare CPS & VNDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CPS
- VNDA
- Stock Information
- Founded
- CPS 1960
- VNDA 2002
- Country
- CPS United States
- VNDA United States
- Employees
- CPS N/A
- VNDA N/A
- Industry
- CPS Auto Parts:O.E.M.
- VNDA Biotechnology: Pharmaceutical Preparations
- Sector
- CPS Consumer Discretionary
- VNDA Health Care
- Exchange
- CPS Nasdaq
- VNDA Nasdaq
- Market Cap
- CPS 250.0M
- VNDA 237.9M
- IPO Year
- CPS N/A
- VNDA 2006
- Fundamental
- Price
- CPS $12.14
- VNDA $4.36
- Analyst Decision
- CPS
- VNDA Strong Buy
- Analyst Count
- CPS 0
- VNDA 2
- Target Price
- CPS N/A
- VNDA $16.50
- AVG Volume (30 Days)
- CPS 390.4K
- VNDA 733.3K
- Earning Date
- CPS 05-01-2025
- VNDA 05-07-2025
- Dividend Yield
- CPS N/A
- VNDA N/A
- EPS Growth
- CPS N/A
- VNDA N/A
- EPS
- CPS N/A
- VNDA N/A
- Revenue
- CPS $2,730,893,000.00
- VNDA $198,772,000.00
- Revenue This Year
- CPS $5.20
- VNDA $14.36
- Revenue Next Year
- CPS $6.33
- VNDA $44.53
- P/E Ratio
- CPS N/A
- VNDA N/A
- Revenue Growth
- CPS N/A
- VNDA 3.18
- 52 Week Low
- CPS $10.38
- VNDA $3.85
- 52 Week High
- CPS $17.76
- VNDA $6.75
- Technical
- Relative Strength Index (RSI)
- CPS 41.46
- VNDA 44.06
- Support Level
- CPS $11.61
- VNDA $4.27
- Resistance Level
- CPS $12.87
- VNDA $4.46
- Average True Range (ATR)
- CPS 1.16
- VNDA 0.21
- MACD
- CPS -0.14
- VNDA 0.01
- Stochastic Oscillator
- CPS 35.88
- VNDA 71.64
About CPS Cooper-Standard Holdings Inc.
Cooper-Standard Holdings Inc is a supplier of rubber and resin products for the automotive industry. The company produces rubber and plastic sealings, fuel and brake lines, fluid transfer hoses, and anti-vibration systems used by original equipment manufacturers and replacement markets for passenger vehicles and light trucks. The largest customers include Ford, GM, FCA, Peugeot Citroen, and Volkswagen. Cooper Standard generates the majority of its revenue with its sealing systems products such as Fortrex, dynamic and static seals, stainless steel trims, flush glass systems, and variable extrusions.
About VNDA Vanda Pharmaceuticals Inc.
Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products; HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS); Fanapt for the treatment of schizophrenia; and PONVORY. Its other products include VHX-896, ASO Molecules, VQW-765, Tradipitant, VTR-297 and VHX-896. The majority of revenue is derived from the Fanapt product sales. Geographically, the company sells its product predominantly in the United States, and also in Israel, Europe, and Canada.